SCHEMBL844967

SCHEMBL844967

CN(C)CC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3cccs3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
HTT P42858 2/20 0.48
NPSR1 Q6W5P4 1/20 0.44
MAPT P10636 2/20 0.44
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
POLB P06746 2/20 0.40
MEN1 O00255 1/20 0.39
ESR1 P03372 1/20 0.39
KMT2A Q03164 1/20 0.39
ESR2 Q92731 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
PABPC1 P11940 1/20 0.39
APOBEC3A P31941 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13272192 0.90 MAPK1 (0.52) MAPK1L3MBTL1ALDH1A1SMN1; SMN2HTT
SCHEMBL845235 0.90 MAPK1 (0.52) MAPK1L3MBTL1ALDH1A1SMN1; SMN2HTT
SCHEMBL845304 0.90 MAPK1 (0.52) MAPK1L3MBTL1ALDH1A1SMN1; SMN2HTT
SCHEMBL13272186 0.88 MAPK1 (0.51) MAPK1L3MBTL1ALDH1A1SMN1; SMN2HTT
SCHEMBL845288 0.88 MAPK1 (0.51) MAPK1L3MBTL1ALDH1A1SMN1; SMN2HTT
SCHEMBL844902 0.88 ALDH1A1 (0.47) MAPK1ALDH1A1HTTCYP2C9CYP2C19
SCHEMBL844977 0.88 MAPK1 (0.50) MAPK1L3MBTL1ALDH1A1SMN1; SMN2HTT
SCHEMBL845486 0.88 MAPK1 (0.50) MAPK1L3MBTL1ALDH1A1SMN1; SMN2HTT
SCHEMBL13272388 0.80 VHL (0.43) ALDH1A1NPSR1CYP2C9CYP2C19MEN1
SCHEMBL845253 0.80 VHL (0.43) ALDH1A1NPSR1CYP2C9CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed